Applied Materials to Host Investor Meeting on Tuesday, April 6
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
SANTA CLARA, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Applied Materials, Inc. will hold an Investor Meeting on Tuesday, April 6. The virtual event will begin at 11 a.m. ET (8 a.m. PT) and conclude before 2 p.m. ET (11 a.m. PT).
Presenters will include Gary Dickerson, President and CEO, and Dan Durn, Senior Vice President and CFO. The company will discuss its longer-term market outlook, opportunities, strategies, product and technology roadmaps, and financial targets.
The presentations and related materials will be available via a live video webcast on the company’s website at http://www.appliedmaterials.com/company/investor-relations. A replay will be available on the same day before 8 p.m. ET (5 p.m. PT).
About Applied MaterialsApplied Materials, Inc. (Nasdaq: AMAT) is the leader in materials engineering solutions used to produce virtually every new chip and advanced display in the world. Our expertise in modifying materials at atomic levels and on an industrial scale enables customers to transform possibilities into reality. At Applied Materials, our innovations make possible the technology shaping the future. Learn more at www.appliedmaterials.com.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PLUG SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Plug Power, Inc.
- Introducing “Got Your Back,” A Lilly Pulitzer Print with Purpose in support of Baby2Baby
- VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study Presented as Late-Breaking Science at ESC Preventive Cardiology 2021